38 related articles for article (PubMed ID: 26907959)
21. Increased regulatory T cells in acute lymphoblastic leukemia patients.
Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M
Hematology; 2015 Oct; 20(9):523-9. PubMed ID: 26119924
[TBL] [Abstract][Full Text] [Related]
22. Frequency of regulatory T cells determines the outcome of the T-cell-engaging antibody blinatumomab in patients with B-precursor ALL.
Duell J; Dittrich M; Bedke T; Mueller T; Eisele F; Rosenwald A; Rasche L; Hartmann E; Dandekar T; Einsele H; Topp MS
Leukemia; 2017 Oct; 31(10):2181-2190. PubMed ID: 28119525
[TBL] [Abstract][Full Text] [Related]
23. [Regulatory T cells in children with acute lymphoblastic leukaemia].
Stasiak-Barmuta A; Łuczyński W; Iłendo E; Krawczuk-Rybak M; Szymański M
Med Wieku Rozwoj; 2009; 13(1):53-8. PubMed ID: 19648661
[TBL] [Abstract][Full Text] [Related]
24. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
[TBL] [Abstract][Full Text] [Related]
25. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV
Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071
[TBL] [Abstract][Full Text] [Related]
26. Increased regulatory T cells in acute lymphoblastic leukaemia patients.
Idris SZ; Hassan N; Lee LJ; Md Noor S; Osman R; Abdul-Jalil M; Nordin AJ; Abdullah M
Hematology; 2016 May; 21(4):206-12. PubMed ID: 26907959
[TBL] [Abstract][Full Text] [Related]
27. Regulatory T cells: a review.
Dasgupta A; Saxena R
Natl Med J India; 2012; 25(6):341-51. PubMed ID: 23998865
[TBL] [Abstract][Full Text] [Related]
28. New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia.
Jordaens S; Cooksey L; Freire Boullosa L; Van Tendeloo V; Smits E; Mills KI; Orchard KH; Guinn BA
Cancer Immunol Immunother; 2020 May; 69(5):867-877. PubMed ID: 31970440
[TBL] [Abstract][Full Text] [Related]
29. Prospect for immunotherapy of acute lymphoblastic leukemia.
Velders MP; ter Horst SA; Kast WM
Leukemia; 2001 May; 15(5):701-6. PubMed ID: 11368429
[TBL] [Abstract][Full Text] [Related]
30. Tisagenlecleucel in pediatric patients with acute lymphoblastic leukemia.
Maude SL
Clin Adv Hematol Oncol; 2018 Oct; 16(10):664-666. PubMed ID: 30543595
[No Abstract] [Full Text] [Related]
31. Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.
Cobaleda C; Vicente-Dueñas C; Sanchez-Garcia I
Nat Rev Immunol; 2021 Sep; 21(9):570-581. PubMed ID: 33558682
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
